| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 08.02.
| Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences | | 18 | PR Newswire |
| SAN DIEGO, Feb. 8, 2012 /PRNewswire/ --Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that Jack Lief, Arena's President and Chief Executive Officer, and Dominic P. Behan, Ph.D., Arena's...
Mehr lesen zu:
Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences | |
| 06.02.
| Hot Stock: Arena Pharmaceuticals, Shares Gain 7.5% | | 8 | SmarTrend |
| 02.02.
| Arena Pharma Gets Notice From FDA Of Advisory Committee Meeting For Lorcaserin | | 97 | AFX News |
| TOKYO (dpa-AFX) - Arena Pharmaceuticals Inc. (ARNA) and Eisai Inc. announced
that the US Food and Drug Administration has notified Arena that an
Endocrinologic and Metabolic Drugs Advisory...
Mehr lesen zu:
Arena Pharma Gets Notice From FDA Of Advisory Committee Meeting For Lorcaserin | |
| 01.02.
| Arena Pharmaceuticals Receives Notice from FDA of Advisory Committee Meeting for Lorcaserin | | 31 | PR Newswire |
| SAN DIEGO, and WOODCLIFF LAKE, N.J., Feb. 1, 2012 /PRNewswire/ --Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) and Eisai Inc. announced today that the US Food and Drug Administration (FDA) has notified...
Mehr lesen zu:
Arena Pharmaceuticals Receives Notice from FDA of Advisory Committee Meeting for Lorcaserin | |
| 31.01.
| Biotech Industry Rallies -- Arena Pharmaceuticals and XOMA Poised for Growth / Paragon Report Provides Equity Research on Arena Pharmaceuticals & XOMA Corporation | | 58 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 01/31/12 -- Biotechnology stocks have been on a tear this month, gaining an impressive 11 percent. Reuters recently released an article arguing health-care costs are...
Mehr lesen zu:
Biotech Industry Rallies -- Arena Pharmaceuticals and XOMA Poised for Growth / Paragon Report Provides Equity Research on Arena Pharmaceuticals & XOMA Corporation | |
| 30.01.
| Traders Get Bullish on Shares of Arena Pharmaceuticals, Shares Up 6.9% | | 13 | SmarTrend |
| 29.01.
| Arena Pharmaceuticals Has Over A 300% Upside Potential In 2012 | | 20 | Seeking Alpha |
| 17.01.
| Arena Pharmaceuticals Faces FDA Decision For Second Time | | 15 | Seeking Alpha |
| 12.01.
| Obesity Drug Candidates From Arena Pharmaceuticals and Vivus Look to Make Big Splash in 2012 / Five Star Equities Provides Stock Research on Arena Pharmaceuticals & Vivus | | 50 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 01/12/12 -- Biotechnology firms focused on Obesity drugs have begun to rally in the early stages of 2012 as key FDA meetings are expected to take place this year. The...
Mehr lesen zu:
Obesity Drug Candidates From Arena Pharmaceuticals and Vivus Look to Make Big Splash in 2012 / Five Star Equities Provides Stock Research on Arena Pharmaceuticals & Vivus | |
| 11.01.
| Arena Pharma (ARNA) Enters $33M Financing Agreement with Deerfield Management | | 2 | StreetInsider.com |
| 11.01.
| Arena Pharmaceuticals Announces $33 Million Financing | | 65 | PR Newswire |
| SAN DIEGO, Jan. 11, 2012 /PRNewswire/ --Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that it has agreed to sell 9,953,250 shares of its common stock, at a price of $1.65775 per share...
Mehr lesen zu:
Arena Pharmaceuticals Announces $33 Million Financing | |
| 10.01.
| Stock to Watch: Arena Pharmaceuticals Up 13.0% | | 2 | SmarTrend |
| 10.01.
| Arena Pharma, Eisai Say FDA Accepted Resubmission Of Lorcaserin NDA | | 79 | AFX News |
| WASHINGTON (dpa-AFX) - Arena Pharmaceuticals, Inc. (ARNA) and Eisai Inc.
said the FDA has accepted for filing and review Arena's resubmission of the New
Drug Application, or NDA, for lorcaserin....
Mehr lesen zu:
Arena Pharma, Eisai Say FDA Accepted Resubmission Of Lorcaserin NDA | |
| 10.01.
| Arena Pharmaceuticals Announces FDA Accepts Resubmission of Lorcaserin New Drug Application | | 3 | Benzinga.com |
| 10.01.
| Arena Pharma (ARNA) says FDA accepts resubmission of Lorcaserin NDA; sets PDUFA date as June 27th, 2012 | | 5 | StreetInsider.com |
| 05.01.
| Arena Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference | | 35 | PR Newswire |
| SAN DIEGO, Jan. 5, 2012 /PRNewswire/ --Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the company is scheduled to present at the 30th Annual J.P. Morgan Healthcare Conference...
Mehr lesen zu:
Arena Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference | |
| 04.01.
| Stock to Watch: Arena Pharmaceuticals Up 5.1% | | 7 | SmarTrend |
| 04.01.
| Arena Pharma Submits Additional Data With FDA For Weight Loss Drug | | 93 | AFX News |
| WASHINGTON (dpa-AFX) - Arena Pharmaceuticals, Inc.(ARNA) Tuesday said it has
submitted additional data with the U.S. Food and Drug Administration related to
its obesity drug candidate lorcaserin....
Mehr lesen zu:
Arena Pharma Submits Additional Data With FDA For Weight Loss Drug | |
| 03.01.
| Arena Pharma Submits Response To FDA Complete Response Letter For Lorcaserin | | 68 | AFX News |
| WASHINGTON (dpa-AFX) - Arena Pharmaceuticals Inc. (ARNA) and Eisai Inc.
announced that Arena has submitted its response to the Complete Response Letter
or CRL issued by the US Food and Drug...
Mehr lesen zu:
Arena Pharma Submits Response To FDA Complete Response Letter For Lorcaserin | |
| 27.12.
| Possible Bullish Inside Day Candle Pattern Detected for Arena Pharmaceuticals | | 9 | SmarTrend |
